Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05925816 · ClinicalTrials.gov registry record · NA
Guided Feedback in an Online Game Impacts Decision Making
A NA study of Depressive Symptoms, sponsored by Bard College.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT05925816: Completed NA study of Depressive Symptoms, sponsored by Bard College.
NCT05925816 is a NA study of Depressive Symptoms that has completed, run by Bard College. The registered enrollment target is 350 participants, above the 256-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05925816, a NA study of Depressive Symptoms, has completed, sponsored by Bard College.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the use of a text-based game as a way to understand decision making and knowledge related to anxiety, stress, and mood states like depression or loneliness. The investigators are interested in identifying whether participants who are given feedback before and during the game will report changes in behavior or depressive symptoms over the course of a one-week period. This is a follow-up to the published study from the researchers.
Primary Outcome
The PHQ measures depression; scores range from 0 to 24 with higher scores indicating more depression.
Conditions Studied
Interventions
- BEHAVIORAL Video
- BEHAVIORAL Active game
- BEHAVIORAL Neutral game
Study Locations (1)
New York
- Bard College - Annandale-on-Hudson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2022-05-04 |
| Phase | NA |
What the finished NCT05925816 record still lists
NCT05925816 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 256-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (37% higher).
The record links to 1 condition, with Depressive Symptoms appearing as the primary indexed condition, and to 3 interventions - of which Video is the first listed.
NCT05925816 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05925816 about?
NCT05925816 is a clinical study titled "Guided Feedback in an Online Game Impacts Decision Making". The purpose of the study is to evaluate the use of a text-based game as a way to understand decision making and knowledge related to anxiety, stress, and mood states like depression or loneliness. The investigators are interested in identifying whether participants who are given feedback before and ...
What is the current status of trial NCT05925816?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2022-02-02. Estimated completion is 2022-05-04.
What conditions does trial NCT05925816 study?
This clinical trial studies the following conditions: Depressive Symptoms.
What interventions are being tested in trial NCT05925816?
The interventions under investigation include: Video (BEHAVIORAL), Active game (BEHAVIORAL), Neutral game (BEHAVIORAL).
Who is sponsoring clinical trial NCT05925816?
This trial is sponsored by Bard College, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05925816 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05925816's enrollment target sits among peer trials
350 8th of 60 higher than 53 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI